| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |